News

Under the deal, Novartis will acquire the exclusive global development and marketing rights to MOR106 for atopic dermatitis and all other potential indications. Based on the achievement of

Janssen Sciences Ireland is a subsidiary of Janssen R&D Ireland. Sylvant has approvals for the treatment of idiopathic multicentric Castleman’s disease (iMCD) in more than 40 countries such as

The study showed that patients who secured two doses of tanezumab separated by eight weeks experienced a statistically significant improvement in pain, physical function and the patients’ overall

Financial details have not been disclosed. Proleukin® is licensed in around 20 countries around the world and is primarily indicated for use in metastatic renal cell carcinoma, as

Baloxavir marboxil was discovered by Shionogi & Co. and is being developed globally by the Roche Group (which includes Genentech in the US) and Shionogi & Co. The drug

TPOXX is claimed to be the first drug with an indication for treatment of smallpox, which is a contagious and fatal infectious disease. The approval of small-molecule antiviral

The partnership will engage in the discovery and development of next-generation bispecific immunotherapies for multiple cancer indications. Under the deal, Immatics will secure an upfront fee of $54m

As of August 2018, a new Logistics Hub in Santiago de Chile will benefit the growing pharma & healthcare industry in South America with a dedicated warehousing solution.

Visterra is engaged in the development of advanced antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases. Otsuka Pharmaceutical representative director and president